Citadel Advisors - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is and the CUSIP is 363256958. A total of 3 filers reported holding GALENA BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q2 2016$13,000
-77.6%
28,900
-26.5%
0.00%
Q4 2015$58,000
-49.6%
39,300
-46.2%
0.00%
Q3 2015$115,000
-29.9%
73,000
-24.2%
0.00%
Q2 2015$164,000
+178.0%
96,300
+126.6%
0.00%
Q1 2015$59,000
+18.0%
42,500
+28.0%
0.00%
Q4 2014$50,000
-31.5%
33,200
-5.7%
0.00%
Q3 2014$73,000
-64.2%
35,200
-47.2%
0.00%
Q2 2014$204,000
-18.1%
66,700
-33.0%
0.00%
Q1 2014$249,000
-27.0%
99,500
+44.8%
0.00%
Q4 2013$341,000
+248.0%
68,700
+59.8%
0.00%
Q3 2013$98,000
+157.9%
43,000
+150.0%
0.00%
Q2 2013$38,00017,2000.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q2 2013
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,291$287,0000.02%
GROUP ONE TRADING, L.P. 22,100$49,0000.00%
Citadel Advisors 17,200$38,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders